Innospec Inc (IOSP)

Return on equity (ROE)

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Net income (ttm) US$ in thousands 139,000 127,000 126,400 129,600 133,000 131,300 116,000 106,000 92,800 91,700 81,000 19,000 28,700 37,200 54,600 116,500 112,100 101,500 92,000 91,600
Total stockholders’ equity US$ in thousands 1,147,100 1,125,400 1,092,200 1,078,200 1,038,000 1,089,400 1,067,900 1,068,200 1,032,400 992,500 973,600 958,600 944,400 -64,300 899,200 943,800 -74,400 881,800 862,700 848,400
ROE 12.12% 11.28% 11.57% 12.02% 12.81% 12.05% 10.86% 9.92% 8.99% 9.24% 8.32% 1.98% 3.04% 6.07% 12.34% 11.51% 10.66% 10.80%

December 31, 2023 calculation

ROE = Net income (ttm) ÷ Total stockholders’ equity
= $139,000K ÷ $1,147,100K
= 12.12%

Innospec Inc's return on equity (ROE) has shown a positive trend over the past eight quarters, ranging from 9.94% in Q1 2022 to 12.81% in Q4 2022. The company's ROE peaked in Q4 2022 before experiencing a slight decline in the subsequent quarters. Despite the fluctuations, the ROE has generally remained above 10% during this period, indicating that the company is effectively generating profits from its shareholder equity. With ROE values consistently in the double digits, it suggests that Innospec Inc is utilizing its equity efficiently to generate returns for shareholders. Overall, the trend in ROE for Innospec Inc reflects a solid financial performance and effective management of shareholder equity.


Peer comparison

Dec 31, 2023